BEIJING, May 21, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter financial results for the period ended March 31, 2014.
First Quarter 2014 Financial Highlights (period-over-period comparisons to first quarter 2013)
-- Quarterly sales increased by 34.8% to $13.5 million from $10.1 million.
Help employers find you! Check out all the jobs and post your resume.